Cargando…
Temporal resolution of idiopathic granulomatous mastitis with resumption of bromocriptine therapy for prolactinoma
INTRODUCTION: Idiopathic granulomatous mastitis (IGM) is becoming more commonly recognized and reported more often. Currently, many recommend corticosteroids in its management. PRESENTATION OF CASE: A 34-year-old G3P2 Hispanic female, 28 weeks pregnant, presented with a 19 cm right breast mass. She...
Autores principales: | Bouton, Marcia E., Winton, Lisa M., Gandhi, Sonal G., Jayaram, Lakshmi, Patel, Prahladbhai N., O’ Neill, Patrick J., Komenaka, Ian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429849/ https://www.ncbi.nlm.nih.gov/pubmed/25781920 http://dx.doi.org/10.1016/j.ijscr.2015.02.051 |
Ejemplares similares
-
SAT612 Granulomatous Mastitis: An Unusual Presentation Of Prolactinoma
por: Alkaissi, Hussam R, et al.
Publicado: (2023) -
Recurrent Priapism From Cabergoline and Bromocriptine in a
Hypogonadal Man With Prolactinoma
por: Menon, Lakshmi P., et al.
Publicado: (2021) -
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995) -
Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
por: Cho, Kyung Rae, et al.
Publicado: (2013) -
Differential Diagnosis in Idiopathic Granulomatous Mastitis and Tuberculous Mastitis
por: Seo, Hee Ri Na, et al.
Publicado: (2012)